Keywords: ریتونویر; Ritonavir; Proliposomes; Central Composite Design; Biotin; Lymphatic targeting;
مقالات ISI ریتونویر (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ریتونویر; Solid dispersions; Ritonavir; Efavirenz; Nanoparticles; Precipitation; Solubility;
Keywords: ریتونویر; in vitro/in vivo correlations (IVIVC); hepatic transport; hepatic metabolism; hepatic clearance; hepatocytes; HIV/AIDS; membrane transport; metabolism; organic anion-transporting polypeptide transporters; APV; amprenavir; ATV; atazanavir; CHO; Chinese h
Keywords: ریتونویر; Binary amorphous forms; Ritonavir; Quercetin; Solubility; Solid-state characterization; Bioavailability
Keywords: ریتونویر; drug interactions; glycyrrhizin; ombitasvir; paritaprevir; ritonavir; ursodeoxycholic acid;
Keywords: ریتونویر; Interacciones medicamentosas; Rabdomiólisis; Insuficiencia renal; Hepatotoxicidad; Inhibidores de la hidroximetilglutaril-coA reductasa; Virus de la inmunodeficiencia humana; Tratamiento antirretroviral; Ritonavir; Estatinas; SimvastatinaDrug-drug interac
Keywords: ریتونویر; Allergy; Hypersensitivity; Antiretroviral therapy; Highly active antiretroviral therapy; Protease inhibitor; Ritonavir;
Keywords: ریتونویر; Amorphous forms; Solubility; Dissolution; Indomethacin; Ritonavir
Keywords: ریتونویر; Acetylsalicylic acid; Naproxen; Ketoprofen; Ritonavir; Misoprostol; Non-steroidal anti-inflammatory drugs; Intestinal damage
Keywords: ریتونویر; Ritonavir; Estrogenic actions; Estrogen receptor; Macrophage
Keywords: ریتونویر; Ritonavir; Darunavir; Solid dispersion; Spray drying; Cyclodextrins; Solubility
Keywords: ریتونویر; Midazolam; Raltegravir; Ketoconazole; Ritonavir; Rifampin;
Keywords: ریتونویر; SULLE; Sugaring out; Sample preparation; Liquid chromatography; Lopinavir; Ritonavir; Bioanalysis; SALLE;
Keywords: ریتونویر; BCRP; breast cancer resistance protein; BSEP; bile salt export pump; BSP; bromosulfophtalein; CYP; cytochrome P450; day 29 or 36; hepatocyte cultures 29 or 36 days respectively after start of the hepatic differentiation protocol; E17βG; estradiol-17β-d-
Keywords: ریتونویر; Histoplasma capsulatum; Saquinavir; Ritonavir; Itraconazole
In vitro characterization of ritonavir formulations and correlation to in vivo performance in dogs
Keywords: ریتونویر; Ritonavir; Absorption; Biomimetic; Dissolution; IVIVR; Liquid-liquid phase separation; Biphasic; BCS; Partition; Relative bioavailability;
The relevance of co-amorphous formulations to develop supersaturated dosage forms: In-vitro, and ex-vivo investigation of Ritonavir-Lopinavir co-amorphous materials
Keywords: ریتونویر; RTV; Ritonavir; LPV; Lopinavir; RLQC 1:1; co-amorphous Ritonavir-Lopinavir prepared by quench cooling at 1:1â¯M ratio; RLQC 1:2; co-amorphous Ritonavir-Lopinavir prepared by quench cooling at 1:2â¯M ratio; RLQC 2:1; co-amorphous Ritonavir-Lopinavir prep
Nanotherapeutics with suitable properties for advanced anticancer therapy based on HPMA copolymer-bound ritonavir via pH-sensitive spacers
Keywords: ریتونویر; Drug delivery; Cell penetration compound; Anticancer therapy; Polymer-based nanotherapeutic; Mitochondrial drug delivery; Multidrug resistance; Ritonavir; HPMA;
Development of ritonavir solid lipid nanoparticles by Box Behnken design for intestinal lymphatic targeting
Keywords: ریتونویر; Ritonavir; Solid lipid nanoparticles; Lymphatic targeting; Compritol; Sodium lauryl sulfate; Bioavailability;
High hepatic exposure of furanocoumarins in Radix Angelica dahuricae is associated with transporter mediated active uptake
Keywords: ریتونویر; ABT; 1-aminobenzotriazole; AUC0-â; area under the curve; BER; bergapten; Cmax; maximum plasma concentration; CsA; cyclosporine A; CYP; cytochrome P450; DMEM/F-12; Dulbecco's modified Eagle medium nutrient mixture F-12; DMSO; dimethyl sulfoxide; Æu; unb
Exploring the feasibility of the use of biopolymers as a carrier in the formulation of amorphous solid dispersions - Part I: Gelatin
Keywords: ریتونویر; Carbamazepine (2554); Cinnarizine (1547484); Darunavir (Ethanolate: 23725083); Fenofibrate (3339); Griseofulvin (441140); Indomethacin (3715); Itraconazole (55283); Ketoconazole (456201); Naproxen (156391); Nifedipine (4485); Ritonavir (392622); Diazepam
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports
Keywords: ریتونویر; Hepatitis C virus (HCV); hemodialysis; cirrhosis; advanced liver fibrosis; sustained virological response; decreased kidney function; end-stage renal disease (ESRD); direct-acting antivirals; paritaprevir; ritonavir; ombitasvir; dasabuvir; ribavirin; HCV
Original ResearchA dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir
Keywords: ریتونویر; Docetaxel; Ritonavir; Oral docetaxel; ModraDoc001; ModraDoc006; Phase I;
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
Keywords: ریتونویر; Hepatitis C, Chronic; Genotype 1; Ombitasvir; Paritaprevir; Ritonavir; Dasabuvir; Ledipasvir; Sofosbuvir; Real-world; Antiviral agents; Sustained virologic response; Randomized controlled trials;
Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection
Keywords: ریتونویر; Routine Clinical Practice; Direct-Acting Antiviral Agents; Cirrhosis; Genotype 4; DAA; direct-acting antiviral agent; EOT; end of treatment; GT; genotype; HCV; hepatitis C virus; LDV; ledipasvir; OMV; ombitasvir; PTV; paritaprevir; r; ritonavir; RBV; riba
Simulations of Cytochrome P450 3A4-Mediated Drug-Drug Interactions by Simple Two-Compartment Model-Assisted Static Method
Keywords: ریتونویر; bioavailability; cytochrome P450; drug interaction; dynamic simulation; first pass metabolism; hepatic clearance; intestinal metabolism; pharmacokinetics; simulations; parallel tube model; Ae (Ae,oral); dose fractions of urinary excreted unchanged drug af
Novel in vitro transport method for screening the reversibility of P-glycoprotein inhibitors
Keywords: ریتونویر; Verapamil; Cyclosporin A; Ritonavir; Quinidine; N-ethylmaleimide; Cremophor® EL; Tween 80; Preactivated thiomers; Rhodamine 123; Caco-2;
Les nouveaux médicaments de l’infectiologie
Keywords: ریتونویر; dasabuvir; lédipasvir; ombitasvir; paritaprévir; ritonavir; sofosbuvir; virus varicelle-zonadasabuvir; ledipasvir; ombitasvir; paritaprevir; ritonavir; sofosbuvir; varicella-zoster virus
Clinical Exposure Boost Predictions by Integrating Cytochrome P450 3A4-Humanized Mouse Studies With PBPK Modeling
Keywords: ریتونویر; clinical pharmacokinetics; CYP enzymes; drug interaction; drug metabolizing enzymes; elimination; hepatic clearance; interspecies scaling; physiologically based pharmacokinetic modeling; preclinical pharmacokinetics; simulations; AUC; area under the plasm
Enabling thermal processing of ritonavir-polyvinyl alcohol amorphous solid dispersions by KinetiSol® Dispersing
Keywords: ریتونویر; KinetiSol Dispersing; Thermal processing; Polymer degradation; Ritonavir; Polyvinyl alcohol;
Research ArticleEfficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials
Keywords: ریتونویر; HCV; hepatitis C virus; GT; genotype; TPV; telaprevir; PegIFN; pegylated interferon; RBV; ribavirin; SVR; sustained virologic response; DAA; direct-acting antiviral agents; OBV; ombitasvir; PTV; paritaprevir; r; ritonavir; DSV; dasabuvir; IL28B; interleuk
Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach
Keywords: ریتونویر; Ritonavir; Nanosuspension; Microfluidization; DoE; HPMC;
Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors
Keywords: ریتونویر; N-(2-hydroxypropyl)methacrylamide copolymers; Multidrug resistance; P-glycoprotein inhibitors; Reversin 121; Ritonavir; Doxorubicin; Pirarubicin; Neuroblastoma;
LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation
Keywords: ریتونویر; Vascular smooth muscle cells; ZMPSTE24; Prelamin A; Senescence; Osteogenic transdifferentiation; Atherosclerosis; ALP; alkaline phosphatase; ATV; atazanavir; DRV; darunavir; HIV; human immunodeficiency virus; LPV; lopinavir; M/R; maraviroc/raltegravir; PB
Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes
Keywords: ریتونویر; DILI; Liver; Nevirapine; Ritonavir; Transcriptomics; 3-D models
Heme oxygenase-1-derived bilirubin counteracts HIV protease inhibitor-mediated endothelial cell dysfunction
Keywords: ریتونویر; PI; protease inhibitors; ROS; reactive oxygen species; HO-1; heme oxygenase-1; CO; carbon monoxide; CORM2; carbon monoxide releasing molecule-2; iCORM2; inactivated carbon monoxide releasing molecule-2; CM-H2DCFDA; 5-(and-6)-chloromethyl-2,7-dichlorodihyd
Increased exposure of norethindrone in HIV + women treated with ritonavir-boosted atazanavir therapyâ
Keywords: ریتونویر; Ritonavir; Norethindrone; Progestin-only contraception; Pharmacokinetics;
Evaluation of plasma microsampling for dried plasma spots (DPS) in quantitative LC-MS/MS bioanalysis using ritonavir as a model compound
Keywords: ریتونویر; Dried plasma spot (DPS) sampling; Plasma microsampling; Dried matrix card; LC-MS/MS; Ritonavir; Quantitative bioanalysis
Development and validation of a stability indicating HPLC method for the simultaneous analysis of lopinavir and ritonavir in fixed-dose combination tablets
Keywords: ریتونویر; Degradation; High-performance liquid chromatography; Lopinavir; Method validation; Ritonavir
Enhanced Boosting of Oral Absorption of Lopinavir Through Electrospray Coencapsulation with Ritonavir
Keywords: ریتونویر; boosting; oral absorption improvement; coaxial electrospray deposition; enteric-coated particle; lopinavir; ritonavir
Simultaneous determination of lopinavir and three ester prodrugs by LC-MS/MS in lysates of BeWo cells
Keywords: ریتونویر; BSA; bovine serum albumin; DLPV; diglycolic acid monoester of lopinavir; DPBS; Dulbecco's phosphate buffered saline; GLPV; glutaric acid monoester of lopinavir; LPV; lopinavir; MRP2; multidrug resistance-associated protein 2; Pgp; P-glycoprotein; RTV; rit
Insuficiencia suprarrenal iatrogénica por la interacción entre ritonavir y fluticasona inhalada. Revisión de la literatura
Keywords: ریتونویر; Fluticasona; Ritonavir; Insuficiencia suprarrenal; CushingFluticasone; Ritonavir; Adrenal insufficiency; Cushing
Development and validation of a systematic UPLC–MS/MS method for simultaneous determination of three phenol impurities in ritonavir
Keywords: ریتونویر; Antiretroviral drugs; Method validation; Ritonavir; Genotoxicity; Solution stability
Effect of ritonavir-induced cytochrome P450 3A4 inhibition on plasma fentanyl concentrations during patient-controlled epidural labor analgesia: a pharmacokinetic simulation
Keywords: ریتونویر; Obstetric Analgesia; Analgesic techniques; Extradural; Pharmacokinetics fentanyl; Ritonavir
Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo
Keywords: ریتونویر; CYP2J2; CYP2D6; CYP3A4; Time dependent inhibition; Ritonavir; In vivo; SimcypAUC, area under the plasma concentration–time curve; CYP, cytochrome P450 monooxygenase; EM, extensive metabolizer; IM, intermediate metabolizer; HLM, human liver microsomes; PM,
Aldehyde dehydrogenase and HSP90 co-localize in human glioblastoma biopsy cells
Keywords: ریتونویر; Aldehyde dehydrogenase; Disulfiram; Glioblastoma; HSP90; Ritonavir; Stem cell; Temozolomide;
Comparative analysis of ER stress response into HIV protease inhibitors: Lopinavir but not darunavir induces potent ER stress response via ROS/JNK pathway
Keywords: ریتونویر; APV; Amprenavir; ARE; antioxidant response; ATV; Atazanavir; cART; Combination antiretroviral therapy; DRV; Darunavir; FDA; Food and Drug Administration; IDV; Indinavir; LDH; lactate dehydrogenase; LPV; Lopinavir; NAC; N-acetyl-L-cysteine; NFV; Nelfinavir
Related factors to atazanavir plasma levels in a cohort of HIV positive individuals with undetectable viral load
Keywords: ریتونویر; Atazanavir; Plasma levels; Drug concentration; Ritonavir; Lipid profile
Taxanes: Old drugs, new oral formulations
Keywords: ریتونویر; Oral; Paclitaxel; Docetaxal; P-glycoprotein; Cytochrome P450; Ritonavir
Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel
Keywords: ریتونویر; Oral paclitaxel; Ritonavir; Ternary solid dispersion; Oral chemotherapy; Low-dose metronomic chemotherapy; PVP